SEC Form 4
Exascale Labs Holdings Inc. (XLAB) insider trading
No open-market XLAB insider purchases or sales were filed in the 12 months to Oct 26, 2026.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $0
- 0 filings
Who traded XLAB, and when
XLAB daily close from Aug 28, 2026 to Oct 26, 2026, between $0.91 and $5.14, last $3.34. No open-market insider purchases or sales were filed in this period.
No open-market insider purchases or sales were filed in the last 12 months.
Open-market trades
0 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | ||||||
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
| No open-market purchases or sales in the last 12 months. | |||||||
GET /stocks/filings/vX/form-4?tickers=XLAB&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"XLAB",
"XLABW"
],
"issuer_cik": "0002109869",
"owner_cik": "0002143167",
"accession_number": "0001829126-26-010804",
"form_type": "4",
"filing_date": "2026-10-06",
"period_of_report": "2026-10-06",
"issuer_name": "Exascale Labs Holdings Inc.",
"issuer_trading_symbol": "XLAB",
"owner_name": "Card David Edward",
"is_director": true,
"is_officer": false,
"is_ten_percent_owner": false,
"is_other": false,
"security_type": "derivative",
"record_type": "transaction",
"security_title": "Restricted Stock Units",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-06",
"transaction_code": "A",
"equity_swap_involved": false,
"transaction_shares": 15000,
"transaction_price_per_share": 0,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 15000,
"transaction_value": 0,
"underlying_security_title": "Class A Common Stock",
"underlying_security_shares": 15000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), upon vesting and settlement."
},
{
"id": "F2",
"description": "The RSUs were granted under the Issuer's 2026 Omnibus Equity Incentive Plan as an Initial Award under the Issuer's Non-Employee Director Compensation Policy. The RSUs vest in full on the earlier of (i) the first anniversary of the grant date and (ii) the scheduled expiration of the Reporting Person's term as a director at an annual meeting of the Issuer's stockholders at which the Reporting Person is not nominated for re-election, in each case subject to the Reporting Person's continued service through the applicable vesting date. The RSUs have no expiration date."
}
]
},
{
"tickers": [
"XLAB",
"XLABW"
],
"issuer_cik": "0002109869",
"owner_cik": "0002139469",
"accession_number": "0001829126-26-010801",
"form_type": "4",
"filing_date": "2026-10-06",
"period_of_report": "2026-10-06",
"issuer_name": "Exascale Labs Holdings Inc.",
"issuer_trading_symbol": "XLAB",
"owner_name": "Lee Hoan Soo",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Executive Officer",
"security_type": "derivative",
"record_type": "transaction",
"security_title": "Restricted Stock Units",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-10-06",
"transaction_code": "A",
"equity_swap_involved": false,
"transaction_shares": 300000,
"transaction_price_per_share": 0,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 300000,
"transaction_value": 0,
"underlying_security_title": "Class A Common Stock",
"underlying_security_shares": 300000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Class A common stock, par value $0.0001 per share (\"Class A Common Stock\"), upon vesting and settlement."
},
{
"id": "F2",
"description": "The RSUs were granted under the Issuer's 2026 Omnibus Equity Incentive Plan pursuant to the Reporting Person's employment agreement with the Issuer. The RSUs vest in three equal installments on August 27, 2027, August 27, 2028 and August 27, 2029, subject to the Reporting Person's continued employment through each such date and to the accelerated vesting provisions of the employment agreement. The RSUs have no expiration date."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Exascale Labs Holdings Inc.'s CEO sold stock?
No. Hoan Soo Lee (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is XLAB’s insider data?
These are XLAB Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track XLAB insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for XLAB every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.